Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Debra Babcock"'
Publikováno v:
Clinical Pediatrics
Autor:
David G. Ingram, Valerie McLaughlin Crabtree, Jodi A. Mindell, Judith A. Owens, Debra Babcock
Publikováno v:
Clinical Pediatrics. 56:5-12
Given the genuine gaps in the availability of clinical sleep services for children, sleep coaching as a field has emerged and appears to be significantly increasing. Sleep coaches are typically individuals who provide individualized services, often v
Autor:
Clemens R. Scherzer, David E. Vaillancourt, Dwight C. German, Debra Babcock, Matthew J. McAuliffe, Barry Landin, Andrew B. West, Chi Tarn, Ted M. Dawson, F. DuBois Bowman, Richard B. Dewey, Liana S. Rosenthal, Xuemei Huang, Daniel Drake, Alice Chen-Plotkin, Coryse St Hillaire-Clarke, Margaret Sutherland, Katrina Gwinn, Roy N. Alcalay, Jing Zhang, Beth Anne Sieber, Vladislav A. Petyuk
Publikováno v:
Movement Disorders. 31:915-923
Background Neuroprotection for Parkinson's disease (PD) remains elusive. Biomarkers hold the promise of removing roadblocks to therapy development. The National Institute of Neurological Disorders and Stroke has therefore established the Parkinson's
Autor:
Stephanie Lowenhaupt, Debra Babcock, Bernard Ravina, Liana Baker, Pei Shieen Wong, Sheng Luo, Pauline LeBlanc, Barbara C. Tilley, Julie H. Carter, Robert A. Hauser, Nabila Dahodwala, Marina E. Emborg, David Simon, Rohit Dhall, John Y. Fang, Andrew Feigin, Richard M. Zweig, Jacci Bainbridge, John C. Morgan, Binit B. Shah, Karen Williams, Kathleen M. Shannon, Buff Farrow, Karl Kieburtz, Daniel D. Truong, Renee Wagner, Cindy Zadikoff, Tanya Simuni, Sofya Glazman, Carlos Singer, Mark F. Lew, Kelvin L. Chou, Rajesh Pahwa, Saloni Sharma, Cornelia Kamp, James T. Boyd, Jordan J. Elm, Maureen A. Leehey, John L. Goudreau, Burton L. Scott, Adriana Pérez, Franca Cambi, Ivan Bodis-Wollner, Anne-Marie Wills, Stephen L. Lee, Jay S. Schneider, G. Webster Ross, Richard B. Dewey
Publikováno v:
The Lancet Neurology. 14:795-803
Summary Background A systematic assessment of potential disease-modifying compounds for Parkinson's disease concluded that pioglitazone could hold promise for the treatment of patients with this disease. We assessed the effect of pioglitazone on the
Autor:
Margaret Sutherland, Susan Dickinson, Jennifer J. Manly, William W. Seeley, Marian Emr, Steven M. Greenberg, Creighton H. Phelps, David M. Holtzman, Debra Babcock, Nina Silverberg, Claudia S. Moy, Angela C. Taylor, Christine L. Torborg, Beth Anne Sieber, Sophia Jeon, David A. Bennett, S. Thomas Carmichael, Salina P. Waddy, P. Scott, Dennis W. Dickson, Jordan T. Gladman, Walter J. Koroshetz, Karen Marder, Amelie K. Gubitz, David S. Knopman, Roderick A. Corriveau, Howard Fillit, Michael Hutton
Publikováno v:
Neurology, vol 89, iss 23
Goal 1 of the National Plan to Address Alzheimer’s Disease is to prevent and effectively treat Alzheimer disease and Alzheimer disease–related dementias by 2025. To help inform the research agenda toward achieving this goal, the NIH hosts periodi
Autor:
Tatiana Foroud, Andrew B. West, David E. Vaillancourt, Roy N. Alcalay, Jing Zhang, Karen K. David, Coryse St Hillaire-Clarke, F. DuBois Bowman, David R. Walt, Vlad Petyuk, Xuemei Huang, Beth Anne Sieber, Rachel Saunders-Pullman, Codrin Lungu, Christine Swanson-Fischer, Katrina Gwinn, Richard B. Dewey, Liana S. Rosenthal, Alice Chen-Plotkin, Roger L. Albin, Ted M. Dawson, Judith A. Potashkin, Margaret Sutherland, Clemens R. Scherzer, Dwight C. German, Debra Babcock
Biomarkers for Parkinson's disease (PD) diagnosis, prognostication and clinical trial cohort selection are an urgent need. While many promising markers have been discovered through the National Institute of Neurological Disorders and Stroke Parkinson
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::833ec22c621710c671aa40628b345674
https://europepmc.org/articles/PMC5619098/
https://europepmc.org/articles/PMC5619098/
Autor:
Michael Hutton, Christine L. Torborg, Dennis W. Dickson, Debra Babcock, Margaret Sutherland, William W. Seeley, Andrey N. Kuzmichev, David S. Knopman, Creighton H. Phelps, Karen Marder, Wendy R. Galpern, Jennifer J. Manly, Roderick A. Corriveau, Thomas J. Montine, Bruce L. Miller, M. Maria Glymour, Steven M. Greenberg, Beth-Anne Sieber, Salina P. Waddy, Berislav V. Zlokovic, Nina Silverberg, Walter J. Koroshetz
Publikováno v:
Neurology. 83:851-860
The National Alzheimer's Project Act, signed into law in 2011, mandates a National Plan to Address Alzheimer's Disease that is updated annually. In the Plan, the term Alzheimer disease includes not only Alzheimer disease (AD) proper, but also several
The Parkinson's Disease Biomarkers Program (PDBP) is a multi-site study designed to identify Parkinson's disease (PD) biomarkers that can be used to improve the understanding of PD pathophysiology and to develop tools that provide novel measures to e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::954f06574e04fed2df9c83b7b4544ff9
https://europepmc.org/articles/PMC4643422/
https://europepmc.org/articles/PMC4643422/
Autor:
Liana S, Rosenthal, Daniel, Drake, Roy N, Alcalay, Debra, Babcock, F DuBois, Bowman, Alice, Chen-Plotkin, Ted M, Dawson, Richard B, Dewey, Dwight C, German, Xuemei, Huang, Barry, Landin, Matthew, McAuliffe, Vladislav A, Petyuk, Clemens R, Scherzer, Coryse St, Hillaire-Clarke, Beth-Anne, Sieber, Margaret, Sutherland, Chi, Tarn, Andrew, West, David, Vaillancourt, Jing, Zhang, Katrina, Gwinn
Publikováno v:
Movement disorders : official journal of the Movement Disorder Society. 31(6)
Neuroprotection for Parkinson's disease (PD) remains elusive. Biomarkers hold the promise of removing roadblocks to therapy development. The National Institute of Neurological Disorders and Stroke has therefore established the Parkinson's Disease Bio
Autor:
Peter Como, Bernard Ravina, Karen Marder, Robert Zalutsky, Diane Murphy, Irene H. Richard, Laura Marsh, William M. McDonald, Emmeline Edwards, Peter Muehrer, Katrina Gwinn-Hardy, Robin Elliott, Matthew Menza, Sharon Stone, Jeffrey L. Cummings, Melinda Kelley, Bonnie Levin, Jeffrey M. Lyness, Robert L. Spitzer, David J. Burn, Margaret Tuchman, Kevin J. Black, Constantine G. Lyketsos, Joseph Friedman, Debra Babcock, Carol Walton, Lynn Morin, Robert M. Hamer, Nancy Abraham, Paul Sheehy, Daniel Weintraub, James Williams, Brenda Tucker
Publikováno v:
Movement Disorders. 21:148-158
Mood disorders are the most common psychiatric problem associated with Parkinson's disease (PD), and have a negative impact on disability and quality of life. Accurate diagnosis of depressive disturbances in PD is critical and will facilitate the tes